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 2 
Abstract 1 
Recent functional genomics and genome-scale modeling approaches indicated that B12 2 
production in Lactobacillus reuteri could be improved by medium optimization. Here we show 3 
that a series of systematic single amino acid omissions could significantly modulate the 4 
production of B12 from nearly undetectable levels (by isoleucine omission) to 20-fold higher than 5 
previously reported through omission of cysteine. We analyzed, by cDNA microarray 6 
experiments, the transcriptional response of L. reuteri to the medium lacking cysteine. These 7 
results supported the observed high B12 production and provided new avenues for future 8 
improvement of production of vitamin B12. 9 
 10 
 3 
Introduction 1 
Vitamin B12 analogues (generally termed B12) form a diverse subgroup of the tetrapyrroles, and 2 
consist of structurally complex molecules that contain a ring-contracted porphinoid with cobalt 3 
chelated at the core (5, 10). Synthesis of B12 is restricted to a few clades of bacteria and archaea, 4 
while vitamin B12 auxotrophies are widely spread in prokaryotes, protists and animals, including 5 
humans (11). 6 
Vitamin B12 is a relevant compound from an anthropocentric perspective. It is an essential 7 
dietary compound (vitamin) with a recommended nutrient intake of 2.4 µg/day for healthy adults 8 
(4) and its deficiency has been associated with several pathologies, namely different forms of 9 
anemia and neurological dysfunction, amongst others (19). Additionally, it is also an industrially 10 
relevant compound since it is an essential co-factor in reactions incorporated in biotechnological 11 
processes, such as the production of 1,3-propanediol (2). 12 
Lactobacillus reuteri is a heterofermentative lactic acid bacterium that colonizes the gastro-13 
intestinal tract of humans and other animals (23). It has been shown to contain a functionally 14 
active B12 biosynthetic gene cluster that encodes all the enzymes required for the synthesis of 15 
this important co-factor from 5-aminolevulinate (12, 14). Catalyzed by glycerol dehydratase (EC 16 
4.2.1.30), a B12-dependent reaction, L. reuteri is able to synthesize 3-hydroxypropanaldehyde 17 
(reuterin) (20). This compound with broad-spectrum antimicrobial activity (1) can be further 18 
reduced to 1,3-propanediol restoring NAD+, if coupled to the oxidation of another carbon source.  19 
We have recently studied the glucose and glycerol co-fermentation by L. reuteri using functional 20 
genomics and genome-scale modeling techniques. This enabled us to broaden our view of the 21 
physiological responses of L. reuteri to glycerol, evidencing strong implications in amino acid 22 
 4 
metabolism and B12 biosynthesis (12). Here, we have focused on these new targets and attempted 1 
to engineer the production of B12 in L. reuteri using physiological approaches. This led to the 2 
discovery that single amino acid omissions can significantly affect the production of B12 in L. 3 
reuteri. Hence, we studied the genome-wide transcriptional response of L. reuteri to the omission 4 
of cysteine in search of mechanistic insights and new leads for metabolic engineering. 5 
 6 
Materials and Methods 7 
Strains, media and culture conditions. We obtained L. reuteri JCM1112 (type-strain, human 8 
isolate) from the Japanese Collection of Microorganisms (Riken, Japan). It was cultured at 37ªC 9 
in an adapted version of chemically defined medium (CDM) from which vitamin B12 was 10 
omitted (22). When appropriate, 0.5% of glycerol was added. Cells were cultivated in standard 11 
non-stirred batch cultures enclosed under an air atmosphere, unless stated otherwise. When 12 
mentioned, oxygen availability was restricted by cultivating L. reuteri in anaerobic jars filled 13 
with either O2-free N2, or a mixture of 95% N2 and 5% CO2. 14 
Single omission growth experiments. We investigated for L. reuteri, the effect on B12 production 15 
and growth behavior, of omitting separately every single amino acid that enters in the 16 
composition of CDM. Parallel experiments were performed in the presence and absence of 17 
glycerol, omitting an amino acid per culture and using a culture without any omission as a 18 
reference. Independent biological duplos were carried out as described. An overnight culture of 19 
L. reuteri washed twice in 0.85 % NaCl (w/v) was used to inoculate all media combinations to an 20 
initial optical density at 600 nm (OD600) of 0.05. Cultures were propagated in batch for five 21 
consecutive transfers in the corresponding media monitoring growth every 24 hours. After 48 22 
 5 
hours, if we could not measure at least two doublings (OD600 < 0.2), the culture would be 1 
discarded and not used for further analysis. If the fourth transfer had an OD600 above 0.5 after 24 2 
hours of incubation, it was used to inoculate 20 ml of the corresponding media. This last culture 3 
was used to determine the maximum specific growth rate (µmax) and the B12 content.  4 
Growth rate determination. L. reuteri JCM1112 was cultivated in the several variations of CDM, 5 
in 96 well microtiterplates (Greiner, Alphen a/d Rijn, The Netherlands). Different replicates were 6 
positioned on the plate using a checkerboard format distribution (3). Plates were incubated at 7 
37°C in a Genios microtiterplate reader (Tecan, Zurich, Switzerland) set to monitor growth by 8 
measuring OD595 every 15 min. All measurements were independently performed at least twice 9 
in at least 8 biological replicates. µmax was determined in a high-throughput fashion by in-house 10 
scripts that calculate µ for every five consecutive time points through out the growth curve and 11 
return its maximum value per well. 12 
Coenzyme B12 determination. B12 production by L. reuteri in the different CDM variations was 13 
determined according to the Official Methods of Analysis of AOAC International, using the L. 14 
delbrueckii subsp. lactis ATCC 7830 vitamin B12 assay (6). Cell extracts for B12 analysis were 15 
prepared as described elsewhere (13). 16 
Fermentation conditions. pH-controlled batch fermentations of L. reuteri in the presence or 17 
absence of cysteine were carried out in an experimental set-up consisting of four vessels with a 18 
reaction volume of 400 ml. Prior to inoculation, the media vessels were gassed with O2-free N2 19 
(15 ml/min) for 1 hour. Temperature was kept constant at 37°C and pH was fixed to 5.8 by 20 
titration with 5 M NaOH. Homogeneity was assured by continuously stirring throughout the 21 
whole fermentation. An exponentially growing culture in the corresponding media was used to 22 
 6 
inoculate the fermentors to an initial OD600 of 0.05. Periodic measurements of OD600 were used 1 
to monitor biomass formation. Samples for transcriptome analysis were harvested at mid-2 
logarithmic growth phase (OD600 1), and in early-stationary phase, 15 minutes after exponential 3 
growth ceased (Fig. 1). At this stage of the growth curve, we also sampled for B12 analysis 4 
(idem). 5 
Microarray design. Dedicated microarrays for L. reuteri JCM1112 were spotted in the high 6 
density Agilent 44K platform (Agilent Technologies, Santa Clara, CA, USA), based on the draft 7 
genome sequence of L. reuteri JCM1112 released by JGI (retrieved in 03/2006). We used the 8 
custom probe design covering 1700 (out of 1900) predicted coding regions (~90% coverage) that 9 
we had developed for the 11K format available at GEO (http://www.ncbi.nlm.nih.gov/geo) under 10 
accession number GPL6856, and had it printed four fold per array. Oligos were designed to 11 
probe the predicted coding regions, representing 82.9% with 24 probes (6 unique) or more, and 12 
only 3.9% with 12 (3 unique) or less.  13 
RNA isolation. Cells harvested from cultures in the presence or absence of cysteine were 14 
sampled by rapid quenching using a cold methanol method (9). Extraction and purification of 15 
total RNA was carried out as previously described (12). RNA concentration was measured on a 16 
ND-1000 spectrophotometer (NanoDrop Technologies Inc., USA). The integrity of the mRNA 17 
species was confirmed on a 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA). A 18 
threshold for the 23S/16S RNA ratio of 1.6 was set for the samples to be considered satisfactory. 19 
Only samples above were used for transcriptome analysis. 20 
cDNA synthesis and labeling. For each sample, 20 µg of RNA were used for first strand cDNA 21 
synthesis using Superscript III reverse transcriptase (Invitrogen, Breda, The Netherlands) 22 
 7 
according to the recommendations of the manufacture. All samples of newly synthesized cDNA 1 
were purified and labeled with cyanine 3 and cyanine 5. Indirect labeling was executed resorting 2 
to the CyScribe first-strand cDNA labeling kit (Amersham, United Kingdom) following 3 
manufacturer’s recommendations. cDNA concentration and labeling incorporation were verified 4 
using the ND-1000 spectrophotometer (NanoDrop Technologies Inc., USA). 5 
Microarray hybridization. We used 0.8 µg of labeled cDNA of each dye per hybridization. All 6 
samples were hybridized with each label at least once to facilitate the recognition of possible dye 7 
effects. A hybridization scheme (supplemental material) consisting of a loop design comprising 8 
13 microarrays was implemented to scrutinize the transcriptome of mid-logarithmic (exp-) and 9 
early-stationary (sta-) growth phase cells cultured in pH-controlled batch fermentations of CDM 10 
from which cysteine was omitted, or not. The hybridizations were performed at 60°C for 17 h, 11 
after which, the slides were washed according to the recommendations of the manufacturer. 12 
Scanning took place immediately after drying the slides as described elsewhere (16). 13 
Scanning and microarray data analysis. Slides were scanned with a ScanArray Express scanner 14 
(Perkin-Elmer) set to maximum resolution (5 µm). ImaGene (BioDiscovery) version 5.6 was 15 
used for image analysis, spot quantification and data extraction. After normalizing the 16 
transcriptome data by local fitting of an M-A plot applying the loess algorithm (24) using the 17 
Limma package (17) in R (http://www.r-project.org), we analyzed the transcriptome data as 18 
described elsewhere (16). Statistical significance was tested from the deviation between 19 
biological duplicates by implementation of the eBayes function included in Limma (cross-probe 20 
variance estimation) and false discovery rate adjustment of the p-values (18). Two comparisons 21 
were established to characterize the impact in L. reuteri of removing cysteine (i) during 22 
 8 
exponential growth phase (mid-logarithmic phase response), and (ii) during early stationary 1 
growth phase (early-stationary phase response). Transcripts were considered for analysis if the p-2 
value was smaller than 0.05 and the absolute Log2 (ratio) greater than 0.585. The transcriptome 3 
data was visualized by projection on metabolic maps of the genome-scale model developed 4 
previously for L. reuteri (12).  5 
Microarray accession numbers. The microarray platform developed in this study is available at 6 
the Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo) (GPL7505). The microarray 7 
data obtained were deposited in the same repository (GSE13391).   8 
 9 
Results 10 
We have recently observed that cultivation of L. reuteri in a chemically defined medium (CDM) 11 
with glycerol has profound implications on B12 production and amino acid metabolism (12). 12 
Here, we followed these newly obtained leads and attempt to modulate the production of B12 by 13 
changing the amino acid composition of CDM and describing the phenotypic changes observed 14 
related to growth and to the production of this co-factor. 15 
Single amino acid omissions and growth of L. reuteri. We found that eight amino acids could be 16 
omitted from CDM without completely inhibiting the growth of L. reuteri. These affected 17 
growth rate and final biomass formation to variable degrees (Table 1). The omission of Serine 18 
(Ser) profoundly reduced the specific growth rate and final optical density both in the absence or 19 
presence of glycerol. In CDM lacking isoleucine (Ile) the final biomass formation is much more 20 
affected than the growth rate. Omission of the other amino acids, namely alanine (Ala), aspartate 21 
(Asp), cysteine (Cys), glycine (Gly), lysine (Lys), or proline (Pro) only slightly affected final 22 
 9 
biomass formation. The growth rates measured in all single amino acid omissions increased with 1 
the addition of glycerol, except for CDM lacking Gly, which was only mildly affected (6% 2 
reduction). 3 
Single amino acid omissions and vitamin B12 production. L. reuteri JCM1112 produces 4 
approximately 20 µg.L-1.OD600-1 of B12 in complete CDM without glycerol. If the latter is added, 5 
B12 production in L. reuteri increases about five fold to 100 µg.L-1.OD600-1. When B12 production 6 
was compared between L. reuteri cultures grown in complete, as opposed to single amino acid 7 
deficient-CDM, a great disparity of effects was observed. (Table 2). The omission of Cys is the 8 
most remarkable since, even without the addition of glycerol, it leads to a 5-fold increase in B12 9 
production relative to complete CDM. Furthermore, the boost in B12 synthesis can also be further 10 
incremented by the presence of glycerol, enabling the accumulation of stimulatory effects, 11 
resulting in over 350 µg.L-1.OD600-1. 12 
The increase in B12 production due to the addition of glycerol, although to varying proportions, 13 
was observed regardless of the amino acid omissions from the composition of CDM. When Ile is 14 
lacking, the largest stimulatory effect of glycerol is registered (20-fold). However, this is caused 15 
by the sharp reduction (greater than 10-fold) in B12 production to levels barely detectable when 16 
glycerol is absent, rather then by an increase of B12 production in CDM with glycerol.  17 
Besides the effects already mention, in the absence of glycerol, L. reuteri produced higher 18 
amounts of B12 in CDM lacking Lys, Ala, Gly and Asp, whilst in its presence, only the omission 19 
of Ala and Asp had a positive effect. 20 
Effect of oxygen on B12 production. Cysteine is known as a potent reducing agent. Omission of 21 
cysteine will lead to increased redox potential and oxygen availability in the growth medium. 22 
 10 
The concentration of oxygen has been reported to affect negatively the production of B12 in 1 
Propionibacteria (7). For this reason, we decided to check whether varying oxygen availability 2 
could alter the stimulatory effect on B12 production caused by the omission of Cys in L. reuteri. 3 
This was done by cultivating in parallel L. reuteri under an air atmosphere conditions, and in an 4 
anaerobic vessel containing either pure N2 or a mixture of 95% N2 with 5% CO2, and checking 5 
B12 production in all possible variations of CDM combining the presence and absence of glycerol 6 
and cysteine (Fig. 2). In 100% N2, the production of B12 was slightly increased by about 30%. 7 
The only exception was the condition in which cysteine is absent and glycerol is present, for 8 
which there is only a trend, but no significant increase (p-value > 0.05). Cultivation in the 9 
presence of 95% N2 with 5% CO2, caused the B12 content to increase slightly more, this time 10 
about 50%. The trend observed for the cultures that combine the absence of cysteine with the 11 
presence of glycerol is even more pronounced. Under this last condition B12 production was 12 
raised to 428 ± 40 µg.L-1.OD600-1. 13 
Transcriptomics of L. reuteri in absence of cysteine. To gain further insight on the stimulatory 14 
effect of Cys in B12 production, we studied the genome-wide transcriptional response of L. 15 
reuteri to cultivation in the absence of Cys, by developing and performing cDNA microarray 16 
experiments. We determined the specific responses in mid-exponential and early-stationary 17 
growth phases. The complete list of loci that were found to be differentially regulated is available 18 
in Table S1 (supplemental material) and a small selection that is discussed in the text is present 19 
in Table 3. 20 
In mid-exponential phase, we found 140 genes differentially regulated, of which only 8 were 21 
found to be down-, while 132 were up-regulated. Concerning genes differently regulated in the 22 
 11 
stationary growth phase, we found 294 genes differentially regulated, 125 down- and 169 up-1 
regulated. A total of 58 genes are shared between both data sets, while 82 were exclusively 2 
differentially regulated in exponential phase and 236 are specific for stationary phase. 3 
In order to facilitate the analysis of the transcriptome data, we examined the distribution of the 4 
genes found to be differentially regulated according to the functional class of the predicted 5 
encoded protein, using the COG classification system (21). The full distribution is available at 6 
Table S2 (supplemental material) and a selection is presented here based on its relevance for the 7 
topics here discussed (Fig. 3). 8 
Not surprisingly, the COG category associated with amino acid transport and metabolism was 9 
overrepresented in both mid-exponential and stationary phase. Specific attention was given to 10 
genes involved in cysteine metabolism. There are 2 genes (lreu_1553 and lreu_1792) annotated 11 
in the chromosome of L. reuteri that are predicted to encode cysteine synthase (EC 2.5.1.47) and 12 
both are up-regulated in the absence of cysteine. The same holds for the genes (lreu_0293-0295, 13 
lreu_0502, lreu_1791) coding for enzymes involved in the metabolism of sulfur-containing 14 
compounds, such as cysteine desulfurase (EC 2.8.1.7), selenocysteine lyase (EC 4.4.1.16) and 15 
cystathionine beta- and gamma-lyases (respectively, EC 4.4.1.8 and EC 4.4.1.1), amongst others. 16 
Genes predicted to encode enzymes related to arginine, aspartate and ornithine tended to be 17 
down-regulated (lreu_0425, lreu_0426 and lreu_0445). The latter have in common that they lead 18 
to the synthesis of carbomyl phosphate, a precursor of pyrimidines. 19 
Harmoniously, genes associated with the COG category that includes proteins assigned to 20 
nucleotide transport and metabolism, are not only overrepresented, but also display a clear 21 
tendency to be down-regulated. Indeed, a closer look clearly shows that a complete cluster 22 
 12 
starting from lreu_0123 to lreu_0127 is drastically down-regulated in the absence of cysteine 1 
(M-value around -5). 2 
Co-factors such as folate derivatives are important in the synthesis of DNA and RNA precursors. 3 
The folate biosynthesis gene cluster (lreu_0510 and lreu_1279-1280, along with the one for 4 
riboflavin (lreu_0878-880) appear down-regulated when cysteine is omitted from CDM and 5 
account for roughly half of the regulated genes assigned to coenzyme transport and metabolism 6 
(Table S1). As expected the B12 biosynthesis gene cluster was up-regulated. 7 
An overrepresentation was observed for genes encoding proteins assigned to COG category 8 
related to posttranslational modification and chaperons. Again the split between up- and down- 9 
regulated appears quite even, implying that the absence of cysteine will not affect 10 
indiscriminately all chaperons. Amongst others, in the down-regulated group we find loci 11 
predicted to encode the co-chaperonin complex GroES and GroEL (lreu_353-354), while in the 12 
up-regulated we can find thioredoxin, thioredoxin reductase (EC 1.8.1.9) and glutaredoxin 13 
(lreu_539, lreu_0376 and lreu_0324, respectively). 14 
One final category worth highlighting is the ion transport and metabolism proteins. Within this 15 
category, most genes were down-regulated, which can be ascribed mainly to the down-regulation 16 
of unspecific ABC transporters. Highly relevant is the finding that the up-regulated group 17 
includes genes involved in the scavenging of cobalt from the environment (lreu_1707-1709). 18 
 19 
Discussion 20 
The average B12 content of an early-stationary culture of L. reuteri JCM1112 in CDM is 21 
approximately 20 µg.L-1.OD600-1. This amount is increased about five fold if CDM is 22 
 13 
supplemented with glycerol. In these conditions, L. reuteri uses glycerol to recycle NAD+ via 1 
the conversion of glycerol to 3-hydroxypropanaldehyde, which is subsequently reduced to 1,3-2 
propanediol (2). The co-fermentation of glucose and glycerol by L. reuteri has recently been 3 
reported to have a major effect on the amino acid metabolism (12). In this study, we have 4 
determined the effect on growth behavior and B12 production of individually omitting the amino 5 
acids present in CDM. This was carried out in parallel in the presence and absence of glycerol. 6 
In this screening exercise, we have identified eight amino acids to be essential for L. reuteri to 7 
grow at least two generations in the first two days after inoculation. The well-established positive 8 
effect of glycerol on the growth rate and B12 production of L. reuteri cultivated in complete 9 
CDM was observed regardless of the omission of the single amino acids with the exception of 10 
glycine (Table 1). When glycine is omitted, the addition of glycerol to CDM still has a positive 11 
effect on B12 production (Table 2), but the effect on µmax is lost. An explanation for this might 12 
reside in the fact that the consumption rate of glycine in the presence of glycerol is nearly twice 13 
as fast as in its absence (12). This is indicative of an increase demand for glycine in the presence 14 
of glycerol, which cannot be met when L. reuteri has to rely solely on de novo synthesis. This 15 
hypothesis is in agreement with the sharp decrease in µmax observed in the absence of glycine and 16 
glycerol, both for L. reuteri and L. plantarum (22). 17 
In the absence of glycerol, the single omission of several amino acids lead to important 18 
increments in B12 production, for instance aspartate 40%, glycine 60%, alanine 200% and lysine 19 
240%. Any of these findings per se could lead to great improvements in B12 production 20 
processes, especially the omission of lysine since it has a very little impact on the growth 21 
behavior of L. reuteri. However, they are completely overshadowed by the 500% increase in B12 22 
 14 
production caused by the omission of cysteine alone. Combined with the stimulatory effect of 1 
glycerol, a 17-fold increase in B12 production was achieved (Table 2). 2 
We have attempted to gain mechanistic insights and new clues on how to further increase the 3 
synthesis of B12 in L. reuteri by studying its genome-wide transcriptional response to the 4 
omission of cysteine. Due to the properties mentioned previously of cysteine as a reducing agent, 5 
we started by carrying out an exploratory experiment under controlled oxygen availability. When 6 
cultured anaerobically, L. reuteri was the first organism reported to produce exclusively 7 
pseudovitamin B12, presenting a great advantage for the downstream processing of its 8 
purification. Under tight anaerobic conditions, B12 production was increased in L. reuteri by little 9 
more than 30%. This could be anticipated, since L. reuteri has been shown to encode the oxygen-10 
independent biosynthetic route towards B12 (14), and the initial step of the industrial production 11 
of B12 using Propionibacteria is carried out under strict anaerobic conditions (7). However, the 12 
increase caused by the absence of cysteine from the medium was not diminished under 13 
anaerobiosis, implying that this amino acid does indeed have other effects in the metabolism of 14 
L. reuteri. When we compare B12 production of cells grown under an anaerobic environment 15 
versus air, combining the omission of cysteine with the addition of glycerol, it is clear that even 16 
though the trend is still there, the increase is not as high as expected. This suggests that after 17 
increasing 20-fold the production of B12 another bottleneck is encountered. 18 
The transcriptome analysis of cells grown in the absence of cysteine in comparison to the ones 19 
grown in complete CDM confirms that indeed in L. reuteri cysteine is made from serine via 20 
cysteine synthase, and using sulfur groups derived from methionine. As mentioned, L. reuteri 21 
contains two copies of cysteine synthase genes (lreu_1553 and lreu_1792), which are up-22 
 15 
regulated in the absence of cysteine. We noticed that while the increased expression of the copy 1 
encoded by lreu_1792 changes very little between the exponential and stationary data sets, its 2 
paralog, lreu_1553 seems to be preferred in the later stages of growth. All pathways from amino 3 
acids to carbomyl phosphate appeared downregulated along with the operon that encodes the 4 
machinery necessary to channel it to pyrimidine biosynthesis. This is most likely related to the 5 
drop in growth rate that we have characterized when cysteine is omitted from CDM (~15% 6 
reduction).  7 
The presence of the B12-biosynthesis gene cluster among the genes that are upregulated in the 8 
absence of Cys was quite expected taking into account the phenotype that we have exposed here. 9 
The fact that we cannot find the full length of the cluster back as up-regulated can be easily 10 
explained by the large size and fragility of the transcribed mRNA species as previously noted 11 
while performing Northern blotting analysis (14). Nonetheless, if we loosen the stringency of our 12 
established thresholds, the whole cluster will prove to have a positive M-value, instead of just the 13 
genes in its centre. Based on the transcriptome data alone, de novo production of riboflavin and 14 
folate seem to be negatively affected by the omission of Cys. Since both of these vitamins are 15 
actually present in CDM in relative excess and we have recently illustrated metabolic 16 
engineering strategies to increase folate production in L. reuteri (15), we decided not to pursue 17 
this any further.  18 
The omission of Cys has implications on sulfur metabolism that extend beyond its own 19 
biosynthesis. The ubiquity of the loci encoding thioredoxin and thioredoxin reductase (EC 20 
1.8.1.9) in both data sets and glutaredoxin in the stationary phase set is illustrative of such. These 21 
are known to reduce other proteins by cysteine thiol-disulfide exchange, acting as antioxidants. 22 
 16 
Here, seems to reside interactions yet to clarify, which could lead to even higher B12 production. 1 
Partially related is cobalt bioavailability. We observed the up-regulation of genes for proteins 2 
involved in the uptake of cobalt, which is logical since this metal is positioned at the core of the 3 
tetrapyrrole macrocycle of B12 (10). Adding more cobalt to CDM supplemented with glycerol 4 
and without cysteine does not yield significant increase in B12 production (data not shown), 5 
which was not unexpected since CDM contains an excess of cobalt. This indicates that the rate of 6 
cobalt supply is a limiting factor that is compensated by increased expression of one or more 7 
cobalt transporters. Bioavailability of cobalt could be the bottleneck that limited the engineering 8 
of B12-production to a 20-fold increase. 9 
Production of vitamin B12 relies solely on microbial production, since chemical methods remain 10 
economically unviable due to the technical complexity of the synthesis process (8). 11 
Pseudomonas denitrificans and Propionibacteria subsp. are accountable for most of the 12 
industrially produced vitamin B12, with a productivity as high as 300 mg.L-1 (8). We have used 13 
physiological approaches to modulate the production of B12 in L. reuteri JCM1112 from nearly 14 
undetectable levels to 20-fold higher than previously reported (15). Although, the production of 15 
B12 obtained in this study using L. reuteri falls short of the maximum reported by nearly two 16 
orders of magnitude, L. reuteri possesses the GRAS status and is a suitable host for in situ 17 
production. Furthermore, we have characterized the impact on growth behavior of all cultivation 18 
conditions tested, and analyzed by cDNA microarray experiments the transcriptional response of 19 
L. reuteri to the omission of cysteine. This has lead to new insights that could be used to improve 20 
even further the production of vitamin B12. 21 
 22 
 17 
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Figure Legends 1 
 2 
Figure 1. Biomass formation and sampling scheme in pH-controlled batch fermentations of 3 
CDM in the presence (solid line) or absence (dashed line) of cysteine. Abbreviations mid-exp 4 
and early-sta stand for mid-exponential and early-stationary growth phase, respectively. 5 
 6 
Figure 2. Vitamin B12 production by L. reuteri under different gas environments in variations of 7 
CDM. -Cys, cysteine omitted; +Glyc, supplemented with glycerol. 8 
 9 
Figure 3. Distribution of transcripts whose expression was affected by the absence of cysteine 10 
during early-stationary growth phase throughout a selection of COGs (see supplemental material, 11 
Table S2 for full distribution). Transcripts were considered to be differentially regulated for M > 12 
|0.585| and p-value < 0.05. Light and dark grey bars represent proportion of up-regulated 13 
transcripts in the absence or presence of cysteine, respectively. Between brackets is the total 14 
number of genes from the genome of L. reuteri included in the corresponding COG. 15 
 22 
Table 1. Growth properties of L. reuteri in single amino acid deficient CDM supplemented or not 1 
with glycerol a. 2 
CDM CDM + glycerol 
Amino acid omission Conc.b. (mM) 
µmax (h-1) Final OD595 µmax (h-1) Final OD595 
Variation 
CDM to 
CDM + 
glycerol 
None n.a. 0.453 (100%) 1.21 (100%) 0.575 (100%) 1.29 (100%) 27% 
Ala 2.69 0.368 (81%) 1.17 (97%) 0.519 (90%) 1.31 (102%) 41% 
Asp 3.16 0.445 (98%) 1.20 (99%) 0.551 (96%) 1.31 (102%) 24% 
Cys 0.83 0.387 (85%) 1.16 (96%) 0.512 (89%) 1.26 (98%) 32% 
Gly 2.33 0.370 (82%) 1.17 (97%) 0.349 (61%) 1.21 (94%) -6% 
Ile 1.60 0.356 (79%) 0.41 (34%) 0.411 (72%) 0.46 (36%) 15% 
Lys 2.68 0.433 (96%) 1.20 (99%) 0.540 (94%) 1.27 (98%) 25% 
Pro 5.86 0.424 (94%) 1.19 (98%) 0.555 (97%) 1.28 (99%) 31% 
Ser 3.24 0.106 (23%) 0.25 (21%) 0.131 (23%) 0.24 (19%) 24% 
a.
 Values are expressed as average (% of same condition without any amino acid omission) of at least 3 
eight biological replicates. Experiment was repeated twice with similar results. 4 
b.
 Concentration of amino acid in CDM when present (n.a., not applicable).  5 
 23 
Table 2. Vitamin B12 production by L. reuteri in single amino acid deficient CDM supplemented 1 
or not with glycerol a. 2 
Amino acid omission CDM CDM + glycerol 
Fold change from 
CDM to 
CDMglycerol 
Fold change relative 
to reference 
conditionb. 
None 21.2 ± 3.6 (100%) 
105.0 ± 17.0 
(100%) 5 5 
Ala 43.2 ± 4.7 (204%) 
143.3 ± 10.9 
(136%) 3 7 
Asp 29.0 ± 4.8 (137%) 
146.8 ± 10.4 
(140%) 5 7 
Cys 103.2 ± 13.0 (488%) 
351.8 ± 28.4 
(335%) 3 17 
Gly 33.0 ± 3.3 (156%) 
113.9 ± 14.1 
(108%) 3 5 
Ile 2.1 ± 0.4 (10%) 
42.4 ± 5.8 
(40%) 20 2 
Lys 50.5 ± 5.1 (239%) 
114.0 ± 22.5 
(109%) 2 5 
Pro 22.0 ± 4.7 (104%) 
72.6 ± 11.9 
(69%) 3 3 
Ser 16.1 ± 3.6 (76%) 
76.0 ± 10.4 
(72%) 5 4 
a.
 Values are expressed as average ± SD (% of same condition without any amino acid omission) of at 3 
least three technical replicates. Experiment was repeated twice with similar results. 4 
b.
 Reference condition is CDM without glycerol added and without any amino acid omission.5 
 24 
Table 3. Selection of differentially regulated genes mentioned in the text (see supplemental 1 
material, Table S1 for full list) 2 
Locus Product Mexp Msta 
Amino acid transport and metabolism 
Lreu_0190 Succinyl-diaminopimelate desuccinylase (EC 3.5.1.18)   -0.70 
Lreu_0293 Cystathionine beta-lyase (EC 4.4.1.8) / Cystathionine gamma-lyase (EC 4.4.1.1) 1.72   
Lreu_0294 Cystine transport system permease protein 1.94 3.23 
Lreu_0295 Cystine transport ATP-binding protein 2.26 3.16 
Lreu_0348 Aspartate aminotransferase (EC 2.6.1.1)   -0.87 
Lreu_0377 Succinyl-diaminopimelate desuccinylase (EC 3.5.1.18)   -1.24 
Lreu_0425 Ornithine carbamoyltransferase (EC 2.1.3.3) -3.38 -0.69 
Lreu_0426 Carbamate kinase (EC 2.7.2.2) -2.27   
Lreu_0445 Arginine deiminase (EC 3.5.3.6) -2.09   
Lreu_0502 Cysteine desulfurase (EC 2.8.1.7)/Selenocysteine lyase (EC 4.4.1.16)   1.16 
Lreu_0610 Diaminopimelate epimerase (EC 5.1.1.7)   -1.07 
Lreu_0611 Aspartokinase (EC 2.7.2.4)   -1.51 
Lreu_0612 Diaminopimelate decarboxylase (EC 4.1.1.20)   -0.70 
Lreu_0613 Tetrahydrodipicolinate N-acetyltransferase (EC 2.3.1.89)   -0.65 
Lreu_1553 Cysteine synthase (EC 2.5.1.47) 1.27 2.06 
Lreu_1791 Homoserine O-succinyltransferase (EC 2.3.1.46) 0.80 1.27 
Lreu_1792 Cysteine synthase (EC 2.5.1.47) 0.96 1.16 
Nucleotide transport and metabolism 
Lreu_0123 Aspartate carbamoyltransferase (EC 2.1.3.2)   -5.32 
Lreu_0124 Dihydroorotase (EC 3.5.2.3)   -5.36 
Lreu_0125 Dihydroorotate dehydrogenase, catalytic subunit (EC 1.3.3.1)   -5.09 
Lreu_0126 Orotidine 5'-phosphate decarboxylase (EC 4.1.1.23)   -4.91 
Lreu_0127 Orotate phosphoribosyltransferase (EC 2.4.2.10)   -4.82 
Coenzyme transport and metabolism 
Lreu_0510 Folylpolyglutamate synthase (EC 6.3.2.17)/Dihydrofolate synthase (EC 6.3.2.12)   -2.33 
Lreu_0878 Diaminohydroxyphosphoribosylaminopyrimidine deaminase (EC 3.5.4.26) / 5-amino-6-(5-phosphoribosylamino)uracil reductase   -0.92 
Lreu_0879 Riboflavin synthase alpha chain (EC 2.5.1.9)   -0.81 
Lreu_0880 GTP cyclohydrolase II (EC 3.5.4.25) / 3,4-dihydroxy-2-butanone-4-phosphate synthase (EC 4.1.2.-)   -0.75 
Lreu_1279 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase (EC 2.7.6.3)   -0.63 
Lreu_1280 Dihydroneopterin aldolase (EC 4.1.2.25)   -0.73 
Lreu_1710 Precorrin-2 C20-methyltransferase (EC 2.1.1.130)   0.71 
Lreu_1711 Sirohydrochlorin cobaltochelatase (EC 4.99.1.3)   0.72 
Lreu_1712 Uroporphyrin-III C-methyltransferase (EC 2.1.1.107) / Uroporphyrinogen-III synthase (EC 4.2.1.75)   0.60 
Posttranslational modification, protein turnover, chaperones 
Lreu_0324 Glutaredoxin   0.71 
Lreu_0353 10 kDa chaperonin GROES   -0.83 
Lreu_0354 60 kDa chaperonin GROEL   -0.84 
Lreu_0376 Thioredoxin reductase (EC 1.8.1.9) 1.11 0.67 
Lreu_0539 Thioredoxin 1.45 0.96 
Inorganic ion transport and metabolism 
Lreu_1707 Cobalt transport protein cbiQ   0.85 
Lreu_1708 Cobalt transport protein cbiN   0.63 
Lreu_1709 CbiM protein   0.69 
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